New Anti-Inflammatory Drugs Pinch Off Reactive Oxygen Species at the Source, Emory University School of Medicine Study  
6/22/2012 7:41:12 AM

Scientists at Emory University School of Medicine have identified a new type of anti-inflammatory compound that may be useful in treating a wide range of conditions, including neurodegenerative and autoimmune diseases. These compounds inhibit the enzyme Nox2, part of a family of enzymes responsible for producing reactive oxygen species (ROS).